{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T19:57:58Z","timestamp":1768334278954,"version":"3.49.0"},"reference-count":5,"publisher":"Health Affairs Publishing, LLC","issue":"Suppl1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Health Affairs"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1377\/hlthaff.27.5.w371","type":"journal-article","created":{"date-parts":[[2008,8,5]],"date-time":"2008-08-05T23:38:44Z","timestamp":1217979524000},"page":"w371-w373","source":"Crossref","is-referenced-by-count":1,"title":["Is Having More Preapproval Data The Best Way To Assure Drug Safety?"],"prefix":"10.1377","volume":"27","author":[{"given":"Alan M.","family":"Garber","sequence":"first","affiliation":[{"name":"Alan Garber () is a staff physician at the Veterans Affairs (VA) Palo Alto Health Care System and the Henry J. Kaiser Jr. Professor and director of the Center for Health Policy and Center for Primary Care and Outcomes Research at Stanford University in Stanford, California."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"102","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.27.5.w360"},{"key":"R3","volume-title":"The Future of Drug Safety: Promoting and Protecting the Health of the Public","author":"Baciu A.","year":"2007"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1927"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.25.5.1218"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsb055203"}],"container-title":["Health Affairs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.healthaffairs.org\/doi\/10.1377\/hlthaff.27.5.w371","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T14:57:26Z","timestamp":1664290646000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.healthaffairs.org\/doi\/10.1377\/hlthaff.27.5.w371"}},"subtitle":["Increased postmarketing surveillance can also play an important role, but the optimal approach must be chosen for each case as it arises."],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":5,"journal-issue":{"issue":"Suppl1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["10.1377\/hlthaff.27.5.w371"],"URL":"https:\/\/doi.org\/10.1377\/hlthaff.27.5.w371","relation":{},"ISSN":["0278-2715","1544-5208"],"issn-type":[{"value":"0278-2715","type":"print"},{"value":"1544-5208","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}